Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)
China · Delayed Price · Currency is CNY 46.95
+1.00 (2.18%)
At close: Jan 23, 2026
SHA:688273 Revenue
Nanjing Medlander Medical Technology had revenue of 102.63M CNY in the quarter ending September 30, 2025, with 0.42% growth. This brings the company's revenue in the last twelve months to 437.82M, up 14.93% year-over-year. In the year 2024, Nanjing Medlander Medical Technology had annual revenue of 424.55M with 24.57% growth.
Revenue (ttm)
437.82M
Revenue Growth
+14.93%
P/S Ratio
10.49
Revenue / Employee
752.27K
Employees
566
Market Cap
4.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 424.55M | 83.72M | 24.57% |
| Dec 31, 2023 | 340.82M | -36.06M | -9.57% |
| Dec 31, 2022 | 376.89M | 35.25M | 10.32% |
| Dec 31, 2021 | 341.64M | 5.12M | 1.52% |
| Dec 31, 2020 | 336.52M | 80.85M | 31.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wuhan Huakang Century Clean Technology | 2.06B |
| Getein Biotech | 1.04B |
| Shanghai Kinetic Medical | 1.02B |
| Zhejiang Orient Gene Biotech | 842.11M |
| Hangzhou AGS MedTech | 668.70M |
| Ningbo David Medical Device | 516.76M |
| Chison Medical Technologies | 449.62M |
| Wuhan Easy Diagnosis Biomedicine | 351.25M |